Design space poorly justified during regulatory submission – regulatory scrutiny risk
Dealing with Inadequate Justification of Design Space in Regulatory Submissions In the pharmaceutical industry, the regulatory scrutiny during submissions can be a critical juncture in the journey from formulation development…